Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...

AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...

At the start of Ben Lerner's startling new novel "Transcription," a man sits on a train trying to read and failing because he ...

The current problem with DeFi is that the organic demand for on-chain credit, borrowing to fund productive economic activity, ...

There are always too many standards to meet and assignments to grade. These strategies can help you reject haste in favor of ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to Bungie, completely literal.

A handful of useful productivity tools wrapped up in a simple shell script.

A new datamine of Borderlands 4 provides some some pretty compelling evidence of the next DLC Vault Hunter coming in Story ...

Bitcoin clawed back above $76,000 at the start of the week, holding firmer than much of the wider digital-asset market even as decentralised finance absorbed the shock of a major exploit tied to ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...